Navigation Links
Agility Clinical Expands Consulting Services to More Broadly Serve Small and Virtual Biopharma and Device Companies
Date:11/8/2012

CARLSBAD, Calif., Nov. 8, 2012 /PRNewswire/ -- Agility Clinical, Inc., a specialty consulting and clinical research organization, has expanded its stand-alone consulting services to more broadly serve the unmet needs of small and virtual biopharma and device companies. The firm helps pre-clinical and clinical stage companies with a lean infrastructure develop drugs and devices by providing strategic and operational consulting support, in addition to traditional CRO services.

"Seasoned industry expertise is essential to deliver value to a sophisticated life science client, and we are very excited to have been able to assemble such a talented and experienced group of individuals.  We can provide expert strategic and operational consulting support to our clients at all stages of clinical development," says Ellen Morgan, CEO of Agility and a 30-year industry veteran. "Agility provides a centralized location where companies can get sound advice that is often vital to their clinical development plans with the ability to respond rapidly to changes and challenges."  Morgan co-founded and was CEO and chairman of Synteract, Inc., a California-based CRO that grew to over 300 employees and provided clinical services to hundreds of companies during her tenure.

Responding to requests from their client base, Agility has added significant resources to its consulting offering which covers all stages of the clinical development process from regulatory strategy to electronic submission, including among other areas, expertise in chemistry, manufacturing, and controls (CMC), toxicology, and pharmacokinetics. Agility also includes executive level support and staffing in its services, with the capability to provide experienced people in positions such as Chief Medical Officer (CMO) or heads of Project Management, Biostatistics and Regulatory Affairs, on a temporary or contract basis. 

"Our goal is to provide guidance and proactive solutions for small and virtual biopharma and device companies so that their product development programs are successful within their timelines and budget constraints," says Marilyn Carlson, D.M.D., M.D., RAC, Vice President of Medical, Regulatory and Scientific Affairs at Agility.

Agility was founded in April 2012 with an experienced executive management team whose mission is to help small and virtual pre-clinical and clinical stage companies develop drugs and devices.  In addition to consulting, Agility provides customized full clinical trial services including project management, clinical operations, data management, biostatistics, medical, regulatory, and scientific affairs, medical writing and electronic source records (ESR). The Agility team has a true appreciation for the challenges virtual companies face in obtaining dedicated expertise they need. Agility has established operations in Carlsbad, CA. For more information, please visit www.agility-clinical.com.

Contact: Amy Zimmerman
A.Z. Communications
619-501-1875
amy@azcommunications.net


'/>"/>
SOURCE Agility Clinical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Elekta to Showcase Revolutionary Agility Beam-shaping Innovation at Radiation Physics Annual Meeting
2. Austrian Medical Center Upgrades Cancer Treatment System, Improves Patient Care with Elektas Agility Beam-shaping Device
3. 90 Presentations at Leading Radiation Oncology Meeting Demonstrate the Breadth and Depth of Clinical Evidence for Accuray Technologies
4. Stemline Therapeutics Lead Clinical Candidate SL-401 Induces a Complete Response in a Patient with a Drug-Refractory Plasmacytoid Dendritic Cell Neoplasm
5. Arisaph Pharmaceuticals Reports Positive Results From Two Safety Clinical Trials For Its Niacin Analog (ARI-3037MO)
6. Greenphires ClinCard Technology Platform selected by top 5 pharmaceutical company for long-term global clinical trial
7. Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting
8. MEI Pharma Reports New Data Showing High Response Rates in Clinical Trial of Pracinostat and Azacitidine in Myelodysplastic Syndrome
9. Zafgen Announces Initiation of Phase 2a Clinical Development with Beloranib in Obesity
10. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2012 Third Quarter Results
11. LABSCO Implements Leading-Edge Technology to Support Growth and Seize Opportunities in the Clinical Laboratory Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
Breaking Medicine Technology:
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
Breaking Medicine News(10 mins):